2025

Annual Report

A Year of Pushing Boundaries

At Moffitt Cancer Center, we believe boundaries are meant to be pushed. Through our innovative science, compassionate cancer care and community outreach, we seek to challenge the status quo and accelerate progress. For we know that each breakthrough we achieve, every patient we reach and each partnership we pursue has the potential to bring us closer to a future without cancer. This year, we expanded our reach in meaningful ways.

Reaching More People

Moffitt’s campus in southern Hillsborough County was designed to expand access to clinical trials to more members of the community.

Expanding Patient Care Through Moffitt at SouthShore

New outpatient campus brings treatment and clinical trials closer to home

Throughout fiscal year 2025, Moffitt health educators hosted 12 clinical trial education sessions across nine counties, reaching 210 individuals.

Spreading Education, Awareness Around Clinical Trials

ACT WONDER2S team hosts sessions in the community to provide straightforward information and dispel myths

Josh Carpenter, DPhil, is leading Speros’ efforts to create a single, integrated environment where drug discovery, development and delivery happen side by side.

Welcoming Speros President Josh Carpenter, DPhil

Josh Carpenter, DPhil, joins Moffitt with the task of guiding one of the most ambitious life sciences initiatives in the nation

From left: Michelle Smith, manager of Moffitt’s mobile screening program; Brenda Connolly, administrator for the Thoracic Oncology Department; Vani Simmons, PhD, director of the Tobacco Research and Intervention Program; and Stephanie Wright, lung cancer screening coordinator, work together to bring lung screenings to outlying communities.

Paving the Way for Lung Cancer Screenings in Communities

Moffitt expands reach with Ferman Family Mobile Screening Unit

Moffitt extends its reach each year through the Business of Biotech conference, which attracts over 400 biotech executives, entrepreneurs, venture capitalists, angel investors and researchers to meet and collaborate on innovations.

Accelerating Impact Through Global Partnership

Moffitt is redefining the cancer treatment landscape through a series of groundbreaking international partnerships

Driving Innovations

Mihaela Druta, MD, was principal investigator on the clinical trial that led to Tecelra’s FDA approval in August 2024. Druta is one of a limited number of specialists who focus on treating patients with sarcoma, a rare type of cancer that develops in connective tissues.

Improving Outcomes for Patients With Synovial Sarcoma

Moffitt treats first patient in the world with FDA-approved Tecelra

Jonathan Strosberg, MD, calls the approval of Cabometyx “a landmark event” for patients and notes the big role Moffitt played in the trial.

FDA Approval Brings Hope for Patients With Rare Neuroendocrine Tumors

Moffitt researchers help bring new therapy to patients with limited treatment options

Dallas Carroll was diagnosed with metastatic HER2-positive breast cancer a week after giving birth. A new immunotherapy treatment has given her hope. From left: Dallas’ stepdaughter Riley, husband Jeremy, and sons Finnry and Dakota.

Dendritic Cell Vaccines Changing Landscape for Breast Cancer Treatment

Moffitt research shows promise in breakthrough immunotherapy treatment

Greg Sawyer, PhD, and Ted Couch see bioengineering as a means of accelerating cancer research and discoveries.

Bringing Vision Into Focus With Nikon Center of Excellence

Philanthropic support and forward-thinking leadership power a new era of innovation in cancer imaging

Going Above and Beyond

Hundreds of Moffitt team members worked around the clock to care for patients as Hurricanes Helene and Milton battered the Bay area in 2024.

In the Eye of the Storm: Care That Never Stops

Moffitt’s mission remains steadfast through Hurricanes Helene and Milton

Bill and Karlie Becker’s wedding funds — totaling more than $15,000 — will support Moffitt’s breast cancer research.

Couple Replace Wedding Gifts With Donations to Cancer Research

Loved ones’ battles inspired heartfelt gift

Ted Couch, H. Lee Moffitt and Florida Agriculture Commissioner Wilton Simpson at the governor's luncheon at the Florida State Fair.

H. Lee Moffitt Named Outstanding Citizen of the Year

Moffitt Cancer Center founder has built a legacy spanning 40 years and counting

Chief Nursing Officer Kelley Gonzalvo, DNP, cuts the ribbon on the new Mission Control Center with, from left, Michael Gonzalez, Miki Williams, Catie Wiernasz and Marina Rivers.

Mission Control Center Optimizes Nursing Care

Centralized space is designed to enhance care coordination, support nursing staff and improve patient experience

Chef Sarah Krieger brings decades of experience as a chef and a dietitian to Moffitt’s research kitchen.

New Moffitt Chef Is Cooking Toward a Cure

Chef brings new flavors and expertise to cancer center's Population Engagement and Research Laboratory

Moffitt at a Glance

Fiscal Year 2025 | July 1, 2024 – June 30, 2025 (PDFs)

Download the PDF

Moffitt Annual Report 2025
(Full Document PDF)

Making an Impact

Your donations help fund powerful cancer-fighting programs. Learn more at Moffitt.org/Give.

Subscribe to Endeavor

Sign up to receive weekly headlines from ENDEAVOR: Subscribe